Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Esophageal Squamous Cell Carcinoma × Trastuzumab × Clear all

Sponsor

Conditions

Breast Neoplasms 208 Stomach Neoplasms 17 Neoplasm Metastasis 13 Breast Neoplasms, Male 13 Neoplasms 8 Esophageal Neoplasms 8 Brain Neoplasms 7 Inflammatory Breast Neoplasms 6 Colorectal Neoplasms 4 Adenocarcinoma Of Esophagus 4 Triple Negative Breast Neoplasms 3 Urologic Neoplasms 2 HER2-positive Breast Cancer 2 Gallbladder Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Ductal, Breast 2 Adenocarcinoma 2 Urinary Bladder Neoplasms 1 Solid Cancers 1 Rectal Neoplasms 1 Patient Preference 1 Patient Compliance 1 Osteitis Deformans 1 Neoplasm, Residual 1 Meningeal Neoplasms 1 Malignant Solid Neoplasm 1 Locally Advanced Breast Cancer 1 Lethal Congenital Contracture Syndrome 2 1 Hormone Receptor Positive Breast Cancer 1

Interventions

Radiotherapy 10 Cisplatin 9 Paclitaxel 8 pembrolizumab 7 Fluorouracil 7 Oxaliplatin 6 Irinotecan 6 Cetuximab 5 tislelizumab 4 Docetaxel 4 Radiation 3 Leucovorin 3 Carboplatin 3 Capecitabine 3 Nivolumab 2 Neoadjuvant Therapy 2 Immunohistochemistry 2 Biopsy 2 10-propargyl-10-deazaaminopterin 2 tremelimumab 1 sitravatinib 1 sintilimab 1 regorafenib 1 pegylated granulocyte colony-stimulating factor, human 1 pegfilgrastim 1 oblimersen 1 durvalumab 1 cixutumumab 1 adavosertib 1 Taxes 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡